Erratum: The A2518G polymorphism of monocyte chemoattractant protein-1 is associated with crohn's disease (American Journal of Gastroenterol (2010) DOI:10.1038/ajg.2010.4);The A2518G polymorphism of monocyte chemoattractant protein-1 is associated with crohn's disease

American Journal of Gastroenterology

Volumn 105, Issue 7, 2010, Pages 1586-1594

  Palmieri, O ^a   Latiano, A ^a   Salvatori, E ^b   Valvano, M R ^a   Bossa, F ^a   Latiano, T ^a   Corritore, G ^a   Di Mauro, L ^a   Andriulli, A ^a   Annesec, Vito ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b Università Politecnica delle Marche ACRAF Gruppo Angelini   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

EID: 77954423116     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.76     Document Type: Erratum

References (45)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-429
2. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
3. Ogura Y, Bonen DK, Inohara N et al. A frame shifmutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-606
4. Rioux JD, Daly M J, Silverberg M S et al. Genetic variationinthe 5q31 cytokine gene cluster confers susceptibility to Crohn's disease. Nat Genet 2001;29:223-228
5. Peltekova VD, Wintle RF, Rubin LA et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 2004;36:471-475
6. Mathew C. New links to the pathogenesis of Crohn disease provided by genome-wide association scans. Nat Rev Genet 2008;9:9-14.
7. Yamazaki K, McGovern D, Ragoussis J et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet 2005;14:3499-3506
8. Duerr RH, Taylor KD, Brant SR et al. A genome-wide association study identifies IL23R as an inf ammatory bowel disease gene. Science 2006;314:1461-1463
9. Hampe J, Franke A, Rosenstiel P et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007;39:207-211 (Pubitemid 46184351)
10. Parkes M, Barrett J C, Prescott N J et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 2007;39:830-832
11. Rioux JD, Xavier RJ, Taylor K D et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates authophagy in disease pathogenesis. Nat Genet 2007; 39: 596-603.
12. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-678
13. Franke A, Hampe J, Rosenstiel P et al. Systematic association mapping identifes NELL1 as a novel IBD disease gene. PLoS ONE 2007;8:1-13.
14. Libioulle C, Louis E, Hansoul S et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genetics 2007;3:e58.
15. Fisher SA, Tremelling M, Anderson C A et al.Genetic determinants of ulcerative colitis include the ECM1 locus and f ve loci implicated in Crohn's disease. Nat Genet 2008; 40: 710-712
16. Ma Y, Ohmen JD, Li Z et al. A genome-wide search identifies potential new susceptibility loci for Crohn's disease. Infamm Bowel Dis 1999;5:271-278
17. Raelson JV, Little RD, Ruether A et al. Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci. Proc Natl Acad Sci USA 2007; 104: 14747-14752
18. Barrett JC, Hansoul S, Nicolae DL et al. Genome-wide association def nes more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008;40:955-962
19. Rollins BJ. Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inf ammatory disease. Mol Med Today 1996;2:198-204.
20. Banks C, Bateman A, Payne R et al. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathol 2003;199:28-35.
21. Grimm MC, Elsbury SK, Pavli P et al. Enhanced expression and production of monocyte chemoattractant protein-1 in inf ammatory bowel disease mucosa. J Leukoc Biol 1996; 59: 804-812
22. Mazzucchelli L, Hauser C, Zgraggen K et al. D i fferential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inf ammator y bowel disease. J Pathol 1996; 178: 201-206
23. Colobran R, Pujol-Borrell R, Armengol MP et al.The chemokine network. II. On how polymorphisms and alternative splicing increase the number of molecular species and conf gure intricate patterns of disease susceptibility. Clin Exp Imm 2007; 150: 1-12.
24. Szalai C, Kozma GT, Nagy A et al. Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol 2001; 108: 375-381
25. Kim MP, Wahl LM, Yanek LR et al. A monocyte chemoattractant protein-1 gene polymorphism is associated with occult ischemia in a high-risk asymptomatic population. Atherosclerosis 2007; 193: 366-372
26. McDermott DH, Yang Q, Kathiresan S et al. CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham hearth study. Circulation 2005;112:1113-1120
27. Aguilar F, Gonzalez-E scribano MF, Sanchez-Roman J et al.M C P -1 promoter polymorphism in Spanish patients with systemic lupus erythema-tosus. Tissue Antigens 2001;58:335-338 (Pubitemid 34095143)
28. Pola R, Flex A, Gaetani E et al. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians. Exp Gerontol 2004;39:1249-1252
29. Papachristou GI, Sass DA, Avula H et al. Is the monocyte chemotactic protein-1-2518 G allele a risk factor for severe acute pancreatitis? Clin Gastroenterol Hepatol 2005; 3: 475-481
30. Simeoni E, Hofmann MM, Winkelmann B R et al.Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus. Diabetologia 2004;47:1574-1580
31. Rovin BH, Lu L, Saxena R. A novel polymorphism in the M C P -1 gen e regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 1999;259:344-348
32. Fenoglio C, Galimberti D, Lovati C et al. MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels. Neurobiol Aging 2004;25:1169-1173 (Pubitemid 39094019)
33. Herfarth H, Goke M, Hellerbrand C et al. Polymorphism of monocyte chem- oattractant protein 1 in Crohn's disease. Int J Colorectal Dis 2003; 18: 401-405
34. Silverberg MS, Satsangi J, Ahmad T et al. Toward an integrated clinical, molecular and serological classification of inf ammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19 (Suppl A): 5-36.
35. Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology 1979;77 (4 Part 2): 843-846
36. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomized study. N Engl J Med 1987;317:1625-1629
37. Sambrook J, Fritsch EF, Maniatis F. Molecular Clonin g: A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, New York, 1989.
38. Cucchiara S, Latiano A, Palmieri O et al. Polymorphisms of tumour necrosis factor-alpha but not MDR1 inf uence response to medical therapy in pediatric-onset infammatory bowel disease. J Pediatr Gastroenterol Nutr 2007;44:171-179
39. Palmieri O, Latiano A, Valvano R et al. Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis. Aliment Phar macol Ter 2006;23:497-506.
40. Fiocchi C. From immune activation to gut tissue injury: the pieces of the puzzle are coming together. Gastroenterology 1999;117:1238-1241
41. Spoettl T, Hausmann M, Herlyn M et al. Monocyte chemoattractant protein-1 (MCP-1) inhibits the intestinal-like differentiation of monocytes. Clin Exp Immunol 2006;145:190-199
42. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet 2007;369:1627-1640
43. Deo R, Khera A, McGuire DK et al. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. Atherosclerosis 2004; 44: 1812-1818
44. Bhatia M, Ramnath RD, Chevali L et al. Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 2005; 288: G1259-65.
45. Guglielmotti A, D'Onofirio E, Coletta I et al. Amelioration of rat adjuvant arthritis by therapeutic treatment with bindarit, an inhibitor of MCP-1 and TNF-alpha production. Inf amm Res 2002; 51: 252-258